海尔生物：完成1亿元股份回购，实控人一致行动人增持

Core Viewpoint - Haier Bio announced a share repurchase plan, with a total expected repurchase amount of 100 to 200 million yuan, aimed at enhancing shareholder value and supporting employee stock ownership plans [1] Group 1: Share Repurchase Details - The repurchase plan was approved on January 13, 2025, with a repurchase period from January 14, 2025, to January 13, 2026 [1] - As of January 13, 2026, the company completed the repurchase of 3.0879 million shares, accounting for 0.9757% of the total share capital, with a total transaction amount of 100 million 42 thousand yuan [1] - The repurchase price ranged from 29.86 to 34.69 yuan per share [1] Group 2: Shareholder Actions - From January 14 to April 10, 2025, the company's actual controller and concerted party, Haichuangzhi, increased its holdings by 3.8535 million shares, bringing the cumulative shareholding ratio to 2.74% [1]